Cost-Effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-Infected Persons with a CD4+ Cell Count ≤100 Cells/μL Who Start HIV therapy in resource-limited settings

David B. Meya, Yukari C. Manabe, Barbara Castelnuovo, Bethany A. Cook, Ali M. Elbireer, Andrew Kambugu, Moses R. Kamya, Paul R. Bohjanen, David R. Boulware

Research output: Contribution to journal › Article › peer-review

257 Scopus citations

Fingerprint

Dive into the research topics of 'Cost-Effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-Infected Persons with a CD4+ Cell Count ≤100 Cells/μL Who Start HIV therapy in resource-limited settings'. Together they form a unique fingerprint.

Medicine & Life Sciences